Diabetes, Vol 43, Issue 4 529-534, Copyright © 1994 by American Diabetes Association

ARTICLES

Protection against adoptive transfer of autoimmune diabetes mediated through very late antigen-4 integrin

LC Burkly, A Jakubowski and M Hattori
Department of Immunology, Biogen, Cambridge, Massachusetts 02142.

The very late antigen-4 (VLA-4) integrin expressed on the surface of lymphocytes and macrophages can regulate their migration to inflammatory sites as well as control cellular activation. The role of VLA-4 in the establishment of autoimmune diabetes is not easily predicted given the multiplicity of adhesion pathways and their differential use by various cell types. The contribution of VLA-4 to insulin-dependent diabetes mellitus was investigated by administration of VLA-4-specific monoclonal antibodies (MoAb) in an adoptive transfer model of disease in NOD mice. This study shows that VLA-4-specific MoAbs profoundly inhibit the development of diabetes with protection sustained by repeated MoAb exposure. Insulitis was completely inhibited during treatment and progressed to a severe degree once MoAb treatment was suspended, yet approximately 40% of treated recipients failed to become diabetic during 1-2 months post-treatment. Although we cannot rule out depletion of a relatively minor subpopulation of cells by prolonged anti-VLA-4 MoAb exposure, this inhibition of diabetes onset by treatment with MoAbs to VLA-4 supports a dependence on VLA-4 for cellular functions leading to diabetes and demonstrates that a significant disease modifying effect can be mediated by targeting the VLA-4 integrin.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Hanninen, R. Nurmela, M. Maksimow, J. Heino, S. Jalkanen, and C. Kurts Islet {beta}-Cell-Specific T Cells Can Use Different Homing Mechanisms to Infiltrate and Destroy Pancreatic Islets Am. J. Pathol., January 1, 2007; 170(1): 240 - 250. [Abstract] [Full Text] [PDF]

				S. Kommajosyula, S. Reddy, K. Nitschke, J. R. Kanwar, M. Karanam, and G. W. Krissansen Leukocytes infiltrating the pancreatic islets of nonobese diabetic mice are transformed into inactive exiles by combinational anti-cell adhesion therapy J. Leukoc. Biol., October 1, 2001; 70(4): 510 - 517. [Abstract] [Full Text] [PDF]

				A. Hanninen, I. Jaakkola, and S. Jalkanen Mucosal Addressin Is Required for the Development of Diabetes in Nonobese Diabetic Mice J. Immunol., June 15, 1998; 160(12): 6018 - 6025. [Abstract] [Full Text] [PDF]

				M. Muñoz, J. Serrador, F. Sánchez-Madrid, and J.ín Teixidó A Region of the Integrin VLAalpha4 Subunit Involved in Homotypic Cell Aggregation and in Fibronectin but Not Vascular Cell Adhesion Molecule-1 Binding J. Biol. Chem., February 2, 1996; 271(5): 2696 - 2702. [Abstract] [Full Text] [PDF]

				L. Ma, P. J. Conrad, D. L. Webb, and M.-L. Blue Aspartate 698 within a Novel Cation Binding Motif in alpha(4) Integrin Is Required for Cell Adhesion J. Biol. Chem., August 4, 1995; 270(31): 18401 - 18407. [Abstract] [Full Text] [PDF]